Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
												
			
			| Line 43: | Line 43: | ||
| ****[[Molecular_Playground/Caspase-7_Dynamics|Caspase-7 Dynamics]] | ****[[Molecular_Playground/Caspase-7_Dynamics|Caspase-7 Dynamics]] | ||
| ****[[Molecular_Playground/Caspase-9_Regulation|Caspase-9 Regulation]] | ****[[Molecular_Playground/Caspase-9_Regulation|Caspase-9 Regulation]] | ||
| + | ***[[User:Greg_Black/Sandbox_1|Cisplatin Information]] | ||
| + | ***[[Michael Purol Sandbox 1|Cyclin Dependent Kinase Inhibitor]] | ||
| ***[[6-deoxyerythronolide_B_synthase_%28DEBS%29|DEBS]] | ***[[6-deoxyerythronolide_B_synthase_%28DEBS%29|DEBS]] | ||
| ***[[Farnesoid X Receptor]] | ***[[Farnesoid X Receptor]] | ||
| Line 61: | Line 63: | ||
| ***[[1ebm|Human 8-Oxoguanine Glycosylase Structure and Mechanism (HOGG1)]] | ***[[1ebm|Human 8-Oxoguanine Glycosylase Structure and Mechanism (HOGG1)]] | ||
| ***Kinases | ***Kinases | ||
| + | ****[[Cory_Tiedeman_sandbox|Cyclin Dependent Kinase-4]] | ||
| ****[[Cell Division Cycle 7-Related Protein Kinase]] | ****[[Cell Division Cycle 7-Related Protein Kinase]] | ||
| ****[[Mammalian Target of Rapamycin]] | ****[[Mammalian Target of Rapamycin]] | ||
| Line 70: | Line 73: | ||
| ****[[Phosphatidylinositol 3-Kinase]] | ****[[Phosphatidylinositol 3-Kinase]] | ||
| ****[[SRC]] | ****[[SRC]] | ||
| + | ***[[Matt Routh sandbox|MDM2 Bound to p53]] | ||
| + | ***[[P-glycoprotein:_Why_Cancer_Drugs_Fail|P-Glycoprotein: Why Cancer Drugs Fail]] | ||
| ***[[p53]] | ***[[p53]] | ||
| + | ***[[Ann_Taylor_sandbox_Proteins_in_Cancer|Proteins in Cancer]] | ||
| + | ***[[Chad Sorenson sandbox 1|Retinoblastoma Protein]] | ||
| ***[[Molecular_Playground/Taxol|Taxol Information]] | ***[[Molecular_Playground/Taxol|Taxol Information]] | ||
| ***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ||
Revision as of 07:49, 26 September 2010
The following is a list of major pharmaceutical compound targets, organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur


